UnitedHealth falls amid report DOJ has launched antitrust review [Seeking Alpha]
Amedisys Inc (AMED)
Last amedisys inc earnings: 2/18 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amedisys.com
Company Research
Source: Seeking Alpha
The DOJ is probing ties between UnitedHealth insurer and its Optum health-services-arm, according to WSJ report on Tuesday, which cited people familiar with the matter. The regulator is interviewing heathcare industry representatives in areas where UnitedHealth competes. Investigtors are asking about potential impacts of the company's doctor-group acquisitions on rivals and consumers, the WSJ reported. Spokespeople for UnitedHealth ( UNH ) and the DOJ declined to comment to the WSJ. Amedisys ( AMED ), which UnitedHealth ( UNH ) agreed to buy in June for $3.3 billion, ticked down 1.2%, amid news of the antitrust probe on Tuesday. Amedisys in August received a request from the DOJ for more information regarding its deal with UNH. In October, Sen. Elizabeth Warren (D-MA) and Rep. Pramila Jayapal (D-WA) asked antitrust regulators to look closely at UnitedHealth's ( UNH ) planned $3.3 billion acquisition of Amedisys ( AMED The DOJ probe comes after the regulator sued in 2022 to
Show less
Read more
Impact Snapshot
Event Time:
AMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMED alerts
High impacting Amedisys Inc news events
Weekly update
A roundup of the hottest topics
AMED
News
- Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Rise [Yahoo! Finance]Yahoo! Finance
- Amedisys, Inc. (NASDAQ: AMED) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Amedisys, Inc. (NASDAQ: AMED) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $101.00 price target on the stock.MarketBeat
- Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]Yahoo! Finance
- Amedisys Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
AMED
Earnings
- 2/21/24 - Miss
AMED
Sec Filings
- 4/26/24 - Form 10-K/A
- 4/25/24 - Form 10-Q
- 4/24/24 - Form 8-K
- AMED's page on the SEC website